Meta-Analysis of the Cystatin C(CST3) Gene G73A Polymorphism and Susceptibility to Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Neuroscience

• Publication date

  2012-03-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00207454.2012.672502PMID 22435454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Lack of an Association between Alzheimer’s Disease and the Cystatin C (CST3) Gene G73A Polymorphism in Mainland Chinese

  2008cited by this paper
• How should we use information about HWE in the meta-analyses of genetic association studies?

  2008cited by this paper
• Estimating genotype relative risks.

  2008cited by this paper
• Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.

  2007cited by this paper
• Cystatin C modulates cerebral β-amyloidosis

  2007cited by this paper
• Cystatin C reduces the in vitro formation of soluble Aβ1‐42 oligomers and protofibrils

  2007cited by this paper
• Genotype and Plasma Concentration of Cystatin C in Patients with Late-Onset Alzheimer Disease

  2007cited by this paper
• Cystatin C modulates cerebral beta-amyloidosis.

  2007cited by this paper
• Cystatin C inhibits amyloid-β deposition in Alzheimer's disease mouse models

  2007cited by this paper
• Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease

  2006influential reference
• Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.

  2006cited by this paper
• Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations.

  2006cited by this paper
• No association between the cystatin C gene polymorphism and Alzheimer's disease: A case-control study in an Italian population

  2005cited by this paper
• Cystatin C as a risk factor for Alzheimer disease

  2005cited by this paper
• Age at Onset: An Essential Variable for the Definition of Genetic Risk Factors for Sporadic Alzheimer's Disease

  2005cited by this paper
• The current status of Alzheimer's disease genetics: what do we tell the patients?

  2004cited by this paper
• Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease

  2004cited by this paper
• Autocrine and Paracrine Calcium Signaling by the CD38/NAD+/Cyclic ADP‐Ribose System

  2004cited by this paper
• Binding of cystatin C to Alzheimer’s amyloid β inhibits in vitro amyloid fibril formation

  2004cited by this paper
• Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.

  2004cited by this paper
• Alzheimer disease-associated cystatin C variant undergoes impaired secretion.

  2003cited by this paper
• Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

  2001cited by this paper
• Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients

  2001cited by this paper
• The cystatin C polymorphism is not associated with early onset Alzheimer’s disease

  2001cited by this paper
• Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease

  2001cited by this paper
• Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

  2000influential reference
• A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease

  2000influential reference
• Codeposition of cystatin C with amyloid-ß protein in the brain of Alzheimer's disease patients

  2000cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Quantitative Synthesis in Systematic Reviews

  1997cited by this paper
• ApoE-4 and Age at Onset of Alzheimer's Disease

  1997cited by this paper
• The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA.

  1995cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.

  1993cited by this paper
• An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism

  1993cited by this paper
• Cystatins--inhibitors of cysteine proteinases.

  1992cited by this paper
• Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.

  1990cited by this paper
• Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C.

  1990cited by this paper
• Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases

  1989cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.

  1982cited by this paper

• MicroRNA-140-5p and cystatin-C expression in patients with vascular cognitive impairment and its clinical value.

  2025cites this paper
• Genome-wide association analysis of cystatin c and creatinine kidney function in Chinese women

  2024cites this paper
• Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer's disease biomarkers.

  2024cites this paper
• LRRC25 expression during physiological aging and in mouse models of Alzheimer’s disease and iPSC-derived neurons

  2024cites this paper
• Cystatins: unravelling the biological implications for neuroprotection

  2023cites this paper
• Analysis of Wild Type and Variant B Cystatin C Interactome in Retinal Pigment Epithelium Cells Reveals Variant B Interacting Mitochondrial Proteins

  2023cites this paper
• Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer’s Disease Datasets Reveals APOE Genotype-Specific Changes Across Cell Types in Two Brain Regions

  2022influential citation
• Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients

  2022cites this paper
• Association of CST3 Gene with Its Protein: Cystatin C in Health and Severe Periodontal Disease

  2021cites this paper
• Sex-Stratified Single-Cell RNA-Seq Analysis Identifies Sex-Specific and Cell Type-Specific Transcriptional Responses in Alzheimer’s Disease Across Two Brain Regions

  2021cites this paper
• The role of vascular dementia associated genes in patients with Alzheimer's disease: A large case–control study in the Chinese population

  2021cites this paper
• Kidney Function Is Not Related to Brain Amyloid Burden on PET Imaging in The 90+ Study Cohort

  2021cites this paper
• Sex-Stratified Single-Cell RNA-Seq Analysis Identifies Sex-Specific and Cell Type-Specific Transcriptional Responses in Alzheimer’s Disease Across Two Brain Regions

  2021cites this paper
• Single-cell transcriptomic analysis elucidates APOE genotype specific changes across cell types in two brain regions in Alzheimer’s disease

  2021cites this paper
• Increased Rate of Retinal Pigment Epithelial Cell Migration and Pro-Angiogenic Potential Ensuing From Reduced Cystatin C Expression

  2020cites this paper
• Mammalian cystatin and protagonists in brain diseases

  2020cites this paper
• Secretory proteostasis of the retinal pigmented epithelium: Impairment links to age-related macular degeneration.

  2020cites this paper
• The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1

  2020cites this paper
• Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients With Alzheimer’s Disease

  2020influential citation
• Effects of Cystatin C on Cognitive Impairment in Older Chinese Adults

  2020cites this paper
• Correlations of serum cystatin C level and gene polymorphism with vascular cognitive impairment after acute cerebral infarction

  2019cites this paper
• CRISPR/Cas9-mediated one step bi-allelic change of genomic DNA in iPSCs and human RPE cells in vitro with dual antibiotic selection

  2019cites this paper
• Clinical Role, Diagnostic and Prognostic Value of Human Cystatin C Through the Body

  2018cites this paper
• Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer’s Disease Mouse Model

  2018cites this paper
• Unraveling the genes implicated in Alzheimer's disease.

  2017cites this paper
• Intracellular Trafficking and Regulation of Variant B Cystatin C in Retinal Pigment Epithelial Cells

  2017cites this paper
• Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?

  2017influential citation
• Evidence of Alternative Cystatin C Signal Sequence Cleavage Which Is Influenced by the A25T Polymorphism

  2016cites this paper
• Amyloid properties of the leader peptide of variant B cystatin C: implications for Alzheimer and macular degeneration

  2016cites this paper
• Cystatin C in aging and in Alzheimer's disease.

  2016cites this paper
• Association of the NQO1 C609T polymorphism with Alzheimer's disease in Chinese populations: a meta-analysis

  2016cites this paper
• Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis

  2015cites this paper
• The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction.

  2015cites this paper
• Expression and regulation of key lysosomal effectors in RPE cells – Implications for Age-related Macular Degeneration (AMD)

  2015influential citation
• Higher Levels of Cystatin C Are Associated with Worse Cognitive Function in Older Adults with Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Cognitive Study

  2014cites this paper
• Age-related changes of cystatin C expression and polarized secretion by retinal pigment epithelium: potential age-related macular degeneration links.

  2014cites this paper
• Role of cystatin C in amyloid precursor protein-induced proliferation of neural stem/progenitor cells*

  2013cites this paper
• Role of Cystatin C in Amyloid Precursor Protein-induced Proliferation of Neural Stem/Progenitor Cells*

  2013cites this paper
• Progenitor Cells Protein-induced Proliferation of Neural Role of Cystatin C in Amyloid Precursor Neurobiology :

  2013cites this paper
• Cystatin C in Alzheimer's disease

  2012cites this paper